Categories: Technology

Legible Announces Appointment of Successor Auditor

| Source: Legible

VANCOUVER, British Columbia, Nov. 01, 2024 (GLOBE NEWSWIRE) — Legible Inc. (CSE: READ) (OTCQB: LEBGF) (FSE: D0T) announces the appointment of DMCL LLP (the “Successor Auditor”) as the Company’s new independent auditor effective immediately.

The Successor Auditor’s appointment has been approved by the Company’s Board of Directors and will be presented for ratification in the next shareholders’ meeting. For a copy of the Company’s reporting package, including the Notice of Change of Auditor, together with the required letters from KPMG LLP (the “Former Auditor” or “KPMG”) and Successor Auditor, each prepared in accordance with the applicable requirements of Section 4.11 of National Instrument 51-102 – Continuous Disclosure Obligations, please visit the Company’s SEDAR+ profile at www.sedarplus.ca.

KPMG resigned on their own initiative, which resignation was reviewed and accepted by Legible’s audit committee. KPMG has confirmed that there are no reportable events, disagreements, unresolved issues, or modifications of opinion (as those terms are defined in National Instrument 51-102 – Continuous Disclosure Obligations in connection with a change of auditor) of the two most recently completed fiscal years that ended December 31, 2023, and 2022, for which an auditor’s report was issued. Legible’s Board of Directors thanks KPMG for their invaluable work.

About Legible Inc.

Legible is a groundbreaking, mobile-centric global company specializing in eBooks and audiobook entertainment. Its extensive partnerships encompass four of the Big 5 Publishers, the world’s largest eBook distributor, and a wide range of outstanding and innovative publishers of all sizes, enabling Legible to seamlessly deliver millions of multilingual eBooks and audiobooks, transforming any smart device into a source of cutting-edge infotainment.

Legible is revolutionizing mobile-centric eBook and audiobook experiences with interactive AI-driven content. Its latest release, FrankensteinAI, third in the AI Classics series, reimagines Mary Shelley’s masterpiece with animated AI art developed by digital artist Remo Camerota and immersive character-driven AI chat, offering readers a uniquely engaging journey through the classic horror tale. Legible is also developing My Model Kitchen, a series of video-enriched Living Cookbooks by former supermodel, bestselling author, and celebrity chef, Cristina Ferrare, with an AI Sous Chef for each recipe, which have been featured twice on the Drew Barrymore Show and in many other major US media outlets.

As first mover in the rapidly expanding automotive infotainment market, Legible has partnered with media providers Faurecia Aptoide, Harman Ignite, LiveOne, and Visteon. Legible has the only Android Automotive app with the capacity to deliver both audiobooks and eBooks to drivers and passengers in tens of millions of vehicles around the globe, positioning Legible at the forefront of the new world of in-car infotainment experiences.

A recent EdTech Breakthrough Award winner for eLearning Innovation of the Year, Legible is reshaping the digital publishing landscape, committed to gaining a significant market share by providing innovative 21st-century publishing solutions and enriching global reading experiences. Please visit Legible.com and discover the place where eBooks come to life.

Press Contacts:

Legible Inc.
Ms. Deborah Harford
EVP, Global Strategic Partnerships
invest@legible.com
Website: https://invest.legible.com
Phone: (778) 776-5769

Krupp Kommunications, Inc.
Ms. Kathy Giaconia
VP Media Relations
kgiaconia@kruppagency.com
Phone: 1-213-324-5665
Website: http://www.KruppAgency.com

Cautionary Note Regarding Forward Looking Information

This Press Release contains certain statements which constitute forward-looking statements or information (“forward-looking statements”), including statements regarding Legible’s business. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Legible’s control, including the impact of general economic conditions, industry conditions, currency fluctuations, the lack of availability of qualified personnel or management, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Legible believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward- looking information. As such, readers are cautioned not to place undue reliance on the forward- looking information, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this document are made as of the date of this document and, except as required by applicable law, Legible does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement.

GlobeNews Wire

Recent Posts

KFSHRC Madinahs Virtual Clinics Wins Award at PX Congress

RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research…

6 hours ago

IBA Business Update Third Quarter 2024

Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in…

6 hours ago

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR…

6 hours ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in…

6 hours ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy,…

6 hours ago

Las Vegas Unveils Exclusive Entertainment, Packages and More for Race Week 2024

Destination Revving up This Year’s Excitement with Top-Tier Entertainment, Luxurious Trackside Experiences and Celebrations like…

9 hours ago